{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:22:18Z","timestamp":1770960138588,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1208\/s12249-018-1205-y","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T18:04:07Z","timestamp":1550081047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Xylan from Pineapple Stem Waste: a Potential Biopolymer for Colonic Targeting of Anti-inflammatory Agent Mesalamine"],"prefix":"10.1208","volume":"20","author":[{"given":"Atsarina Larasati","family":"Anindya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa Dwi","family":"Oktaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benita Rachel","family":"Praevina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophi","family":"Damayanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neng Fisheri","family":"Kurniati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catur","family":"Riani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heni","family":"Rachmawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"1205_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-94-007-6898-7_2","volume-title":"Biotechnology of lignocellulose: theory and practice","author":"H Chen","year":"2014","unstructured":"Chen H. Chemical composition and structure of natural lignocellulose. In: Chen H, editor. Biotechnology of lignocellulose: theory and practice. Dordrecht: Springer; 2014. p. 25\u201371."},{"key":"1205_CR2","first-page":"62","volume-title":"Products and applications of biopolymers","author":"AE da Silva","year":"2012","unstructured":"da Silva AE, Marcelino HR, Gomes MCS, Oliveira EE, Nagashima T Jr, Egito EST. Xylan, a promising hemicellulose for pharmaceutical use. In: Verbeek CJR, editor. Products and applications of biopolymers. Rijeka: InTech; 2012. p. 62\u20135."},{"issue":"18","key":"1205_CR3","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1016\/S0021-9258(18)94282-1","volume":"244","author":"J Scocca","year":"1969","unstructured":"Scocca J, Lee YC. The composition and structure of the carbohydrate of pineapple stem bromelain. J Biol Chem. 1969;244(18):4852\u201363.","journal-title":"J Biol Chem"},{"issue":"14","key":"1205_CR4","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1016\/j.biortech.2010.01.137","volume":"101","author":"EE Oliveira","year":"2010","unstructured":"Oliveira EE, Silva AE, J\u00fanior TN, Gomes MC, Aguiar LM, Marcelino HR, et al. Xylan from corn cobs, a promising polymer for drug delivery: production and characterization. Bioresour Technol. 2010;101(14):5402\u20136.","journal-title":"Bioresour Technol"},{"issue":"4","key":"1205_CR5","first-page":"451","volume":"25","author":"RR Scheline","year":"1973","unstructured":"Scheline RR. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Rev. 1973;25(4):451\u2013523.","journal-title":"Pharmacol Rev"},{"key":"1205_CR6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.carbpol.2016.09.096","volume":"157","author":"Sauraj","year":"2017","unstructured":"Sauraj, Kumar SU, Gopinath P, Negi YS. Synthesis and bio-evaluation of xylan-5-fluorouracil-1-acetic acid conjugates as prodrugs for colon cancer treatment. Carbohydr Polym. 2017;157:1442\u20133 1447\u20131449.","journal-title":"Carbohydr Polym"},{"key":"1205_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.carbpol.2018.02.006","volume":"188","author":"Sauraj","year":"2018","unstructured":"Sauraj, Kumar SU, Kumar V, Priyadarshi R, Gopinath P, Negi YS. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy. Carbohydr Polym. 2018;188:252\u20133 256\u2013257.","journal-title":"Carbohydr Polym"},{"issue":"304","key":"1205_CR8","first-page":"1","volume":"10","author":"W Kong","year":"2017","unstructured":"Kong W, Gao C, Hu S, Ren J, Zhao L, Sun R. Xylan-modified-based hydrogels with temperature\/pH dual sensitivity and controllable drug delivery behavior. Materials. 2017;10(304):1\u20133 9\u201310.","journal-title":"Materials"},{"issue":"7","key":"1205_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.33.7.929","volume":"33","author":"D Rachmilewitz","year":"1992","unstructured":"Rachmilewitz D, Karmeli F, Schwartz LW, Simon PL. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation. Gut. 1992;33(7):929\u201332.","journal-title":"Gut"},{"issue":"1","key":"1205_CR10","first-page":"399","volume":"272","author":"C Stevens","year":"1995","unstructured":"Stevens C, Lipman M, Fabry S, Moscovitch-Lopatin M, Almawi W, Keresztes S, et al. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells. J Pharmacol Exp Ther. 1995;272(1):399\u2013406.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"1205_CR11","doi-asserted-by":"publisher","first-page":"51S","DOI":"10.1007\/BF01312464","volume":"32","author":"BM Peskar","year":"1987","unstructured":"Peskar BM, Dreyling KW, May B, Schaarschmidt K, Goebell H. Possible mode of action of 5-aminosalicylic acid. Dig Dis Sci. 1987;32(12):51S\u20136S.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"1205_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/0016-5085(90)90329-Y","volume":"98","author":"I Ahnfelt-R\u00f8nne","year":"1989","unstructured":"Ahnfelt-R\u00f8nne I, Nielsen OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology. 1989;98(5):1162\u20139.","journal-title":"Gastroenterology"},{"issue":"7","key":"1205_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1155\/1990\/324287","volume":"4","author":"T Yamada","year":"1990","unstructured":"Yamada T, Volkmer C, Grisham MB. Antioxidant properties of 5-ASA: potential mechanism for its anti-inflammatory activity. Can J Gastroenterol. 1990;4(7):295\u2013302.","journal-title":"Can J Gastroenterol"},{"issue":"6\u20137","key":"1205_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/0006-2952(91)90207-L","volume":"41","author":"H Tama","year":"1991","unstructured":"Tama H, Kachur JF, Grisham MB, Gaginella TS. Scavenging effect of 5-aminosalicylic acid on neutrophil-derived oxidants: Possible contribution to the mechanism of action in inflammatory bowel disease. Biochem Pharmacol. 1991;41(6\u20137):1001\u20136.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1205_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1155\/2010\/586092","volume":"24","author":"M Iacucci","year":"2010","unstructured":"Iacucci M, de Silva S, Ghosh S. Mesalazine in inflammatory bowel disease: a trendy topic once again? Can J Gastroenterol. 2010;24(2):127\u201333.","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"1205_CR16","first-page":"1","volume":"6","author":"S Katz","year":"2010","unstructured":"Katz S, Lichtenstein GR, Safdi MA. 5-ASA dose-response, maximizing efficacy and adherence. Gastroenterol Hepatol. 2010;6(2):1\u201316.","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"1205_CR17","first-page":"247","volume":"8","author":"KA Head","year":"2003","unstructured":"Head KA, Jurenka JS. Inflammatory bowel disease part I: ulcerative colitis \u2013 pathophysiology and conventional and alternative treatment options. Altern Med Rev. 2003;8(3):247\u201383.","journal-title":"Altern Med Rev"},{"key":"1205_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.addr.2013.01.003","volume":"65","author":"JM Gamboa","year":"2013","unstructured":"Gamboa JM, Leong KW. In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev. 2013;65:800\u201310 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3773489\/pdf\/nihms453288.pdf .","journal-title":"Adv Drug Deliv Rev"},{"key":"1205_CR19","unstructured":"(724) Drug release. USP 38\u2013NF 33. 38th ed. Rockville, MD: United States Pharmacopeial Convention; 2015. p. 497\u2013504."},{"key":"1205_CR20","first-page":"78","volume":"3","author":"AA Dangi","year":"2013","unstructured":"Dangi AA, Ganure AL, Divya J. Formulation and evaluation of colon targeted drug delivery system of levetiracetam using pectin as polymeric carrier. J Appl Pharm Sci. 2013;3:78\u201387.","journal-title":"J Appl Pharm Sci."},{"key":"1205_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"issue":"3","key":"1205_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics9030024","volume":"9","author":"H Rachmawati","year":"2017","unstructured":"Rachmawati H, Pradana AT, Safitri D, Adnyana IK. Multiple functions of D-\u03b1-tocopherol polyethylene glycol 1000 succinate (TPGS) as curcumin nanoparticle stabilizer: in vivo kinetic profile and anti-ulcerative colitis analysis in animal model. Pharmaceutics. 2017;9(3):1\u201313.","journal-title":"Pharmaceutics"},{"key":"1205_CR23","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Investig. 1993;69:238\u201349.","journal-title":"Lab Investig"},{"key":"1205_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejpb.2004.06.004","volume":"59","author":"M Zou","year":"2005","unstructured":"Zou M, Okamoto H, Cheng G, Hao X, Sun J, Cui F, et al. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery system. Eur J Pharm Biopharm. 2005;59:155\u201360.","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"1205_CR25","first-page":"1995","volume":"4","author":"S Kumar","year":"2012","unstructured":"Kumar S, Negi YS. Corn cob xylan-based nanoparticles: ester prodrug of 5-aminosalicylic acid for possible targeted delivery of drug. J Pharm Sci Res. 2012;4(12):1995\u20132003.","journal-title":"J Pharm Sci Res"},{"issue":"3","key":"1205_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0141-3910(03)00051-X","volume":"80","author":"X Colom","year":"2003","unstructured":"Colom X, Carrillo F, Nogues F, Garriga P. Structural analysis of photodegraded wood by means of FTIR spectroscopy. Polym Degrad Stab. 2003;80(3):543\u20139.","journal-title":"Polym Degrad Stab"},{"key":"1205_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/0471973106","volume-title":"Modern HPLC for practicing scientist","author":"MW Dong","year":"2006","unstructured":"Dong MW. Modern HPLC for practicing scientist. Hoboken: Wiley; 2006."},{"key":"1205_CR28","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","volume":"45","author":"GT Macfarlane","year":"2011","unstructured":"Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol. 2011;45:S120\u20137.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"1205_CR29","first-page":"6","volume":"1","author":"A Rajesh","year":"2012","unstructured":"Rajesh A, Bharat C, Sangeeta A. Oral colon targeted drug delivery system: a review on current and novel perspectives. J Pharm Innov. 2012;1(5):6\u201312.","journal-title":"J Pharm Innov"},{"issue":"7","key":"1205_CR30","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/AEM.03176-13","volume":"80","author":"P Honga","year":"2014","unstructured":"Honga P, Iakiviaka M, Dodd D, Zhanga M, Mackiea RI, Canna I. Two new xylanases with different substrate specificities from the human gut bacterium bacteroides intestinalis DSM 17393. Appl Environ Microbiol. 2014;80(7):2084\u201393.","journal-title":"Appl Environ Microbiol"},{"key":"1205_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.0954-6820.1987.tb00889.x","volume":"221","author":"S Bondesen","year":"1987","unstructured":"Bondesen S, Rasmussen SN, Madsen JR, Nielsen OH, Lauritsen K, Binder V, et al. 5-aminosalicylic acid in the treatment of inflammatory bowel disease. Acta Med Scand. 1987;221:227\u201342.","journal-title":"Acta Med Scand"},{"key":"1205_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/978-3-319-59211-4","volume-title":"The practice of surgical pathology: a beginner\u2019s guide to the diagnostic process","author":"DW Molavi","year":"2018","unstructured":"Molavi DW. The practice of surgical pathology: a beginner\u2019s guide to the diagnostic process. Cham: Springer International Publishing AG; 2018. p. 74."},{"issue":"5","key":"1205_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000171464","volume":"12","author":"J Brynskov","year":"1994","unstructured":"Brynskov J, Nielsen OH, Ahnfelt-R\u00f8nne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis. 1994;12(5):290\u2013304.","journal-title":"Dig Dis"},{"key":"1205_CR34","first-page":"614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 2014;5:614.","journal-title":"Front Immunol"},{"issue":"3","key":"1205_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0017360","volume":"6","author":"L Neeb","year":"2011","unstructured":"Neeb L, Hellen P, Boehnke C, Hoffmann J, Schuh-Hofer S, Dirnagl U, et al. IL- 1\u03b2 stimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One. 2011;6(3):1\u20139.","journal-title":"PLoS One"},{"issue":"1","key":"1205_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","volume":"60","author":"K Ren","year":"2008","unstructured":"Ren K, Torres R. Role of interleukin- 1\u03b2 during pain and inflammation. Brain Res Rev. 2008;60(1):57\u201364.","journal-title":"Brain Res Rev"},{"issue":"6","key":"1205_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/onc.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene. 2010;29(6):781\u20138.","journal-title":"Oncogene"},{"key":"1205_CR38","doi-asserted-by":"publisher","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2. https:\/\/doi.org\/10.1038\/sigtrans.2017.23 .","DOI":"10.1038\/sigtrans.2017.23"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T19:29:09Z","timestamp":1720985349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1205-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed. School of Pharmacy, Bandung Institute of Technology, Indonesia. The approval number is 305\/UN6.C.10\/PN\/2017 (15\/3\/2017).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"112"}}